Hope for rare immune disorder: long-term drug safety tested
Disease control
Terminated
This study looked at the long-term safety and effectiveness of the drug CDZ173 in people with APDS/PASLI, a rare genetic condition that weakens the immune system. Participants had either been in a previous study or had taken similar drugs before. The goal was to see how well the …
Phase: PHASE2, PHASE3 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated May 26, 2026 12:06 UTC